Teva Pharmaceutical Industries (TEVA) Research Hub

Teva Pharmaceutical Industries (TEVA) trades on NYSE, IL in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-09-11, shares last closed at 37.09 USD (+0.65%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 22.49, market cap 35.40B. This hub links to the full technical, earnings and options research available for TEVA.

Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Drug Manufacturers - Specialty & Generic)
ExchangeNYSE, IL
Last close37.09 USD (+0.65%)
52-week range30.13 USD – 38.11 USD
Trend regimeRange
14-day RSI63.4 (Bullish)
Trailing P/E22.49
Market cap35.40B
Dividend yield0.00%
Next earnings2026-07-29

Available research for TEVA

Earnings

TEVA earnings: next report 2026-07-29, real EPS beat/miss history, analyst consensus Buy, P/E 22.49. Updated 2026-07-23.

Options: Covered Call

Covered Call on TEVA: how it works, illustrative setup around the real 37.09 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on TEVA: how it works, illustrative setup around the real 37.09 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on TEVA: how it works, illustrative setup around the real 37.09 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

TEVA technical analysis: range, last 37.09 USD, RSI 63.4, 52w range 30.13 USD–38.11 USD, real support/resistance. Updated 2026-09-11.

Frequently asked questions

What sector is TEVA in?

Teva Pharmaceutical Industries (TEVA) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NYSE, IL.

Is TEVA in an uptrend or downtrend?

As of 2026-09-11, TEVA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is TEVA's trailing P/E ratio?

TEVA's trailing P/E is 22.49, with a market cap of 35.40B. See the earnings research page for full valuation detail.

When does TEVA next report earnings?

TEVA is next scheduled to report earnings on 2026-07-29, with a consensus EPS estimate of 0.04772 USD.